Hentilä, Eerik
Tiihonen, Miia
Taipale, Heidi
Hartikainen, Sirpa
Tolppanen, Anna-Maija
Article History
Received: 17 December 2020
Accepted: 10 March 2021
First Online: 23 March 2021
Declarations
:
: Register maintainers have approved the FINPARK study plan. Data were pseudonymized before submission to the research team and study participants were not contacted. Therefore, according to Finnish legislation (including Personal Data Act 23/1999, Act on the Openness of Government Activities 621/1999 and Act on the Secondary Use of Health and Social Data 552/2019 (and previous Act on the National Healthcare registers, not official English translation as this is not available 556/1989) the study has been granted an exemption from requiring ethics approval or informed consent.
: Not applicable.
: SH reports lecture fees from Astellas Pharma. HT acknowledges personal fees from Janssen Cilag and research grants from Janssen Cilag and Eli Lilly, outside of the submitted work. EH, MT, AMT have nothing to declare.